Anosmia and Ageusia: Common Findings in COVID-19 Patients
Luigi A Vaira, Giovanni Salzano, Giovanna Deiana, Giacomo De Riu, Luigi A Vaira, Giovanni Salzano, Giovanna Deiana, Giacomo De Riu
Abstract
In a not negligible number of patients affected by COVID-19 (coronavirus disease 2019), especially if paucisymptomatic, anosmia and ageusia can represent the first or only symptomatology present. Laryngoscope, 130:1787-1787, 2020.
© 2020 The American Laryngological, Rhinological and Otological Society, Inc.
References
- Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID‐19 in Wuhan, China: a retrospective case series study. MedR 2020;xiv. 10.1101/2020.02.22.20026500.
- Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwan 2006;15:26–28.
- De Haro‐Licer J, Roura‐Moreno J, Vizitiu A, Gonzàlez‐Fernàndez A, Gonzàlez‐Ares JA. Long term serious olfactory loss in cold and/or flu. Acta Otorrinolaringol Esp 2013;64:331–338.
- Suzuki M, Saito K, Min WP, et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 2007;117:272–277.
- Yamagishi M, Fujiwara M, Nakamura H. Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology 1994;32:118–133.
Source: PubMed